Triojection® is indicated for herniated lumbar discs that compress or otherwise irritate the dura or exiting nerve root (as confirmed by patient history supported with MRI or radiographic findings), resulting in leg pain with or without back pain.
Here is a video on how to prepare ozone using the Triojection System.
European Post Market Study
Minimus Spine is enrolling a post market study at select sites in Europe. The objective of this randomized study is to compare the outcomes and costs of Triojection and surgical discectomy. The study seeks to enroll approximately 50 patients. Several sites have been recruited and enrollment started in July 2015. Additional information can be found at clinicaltrials.gov using this link. Contact us if you would like to be considered as a clinical site for this study.
US FDA Study
In the future, Minimus intends to conduct a clinical investigation for FDA approval. This work will likely include of 20-30 centers that perform spinal injections. Contact us if you would like to be considered as a clinical site.